Contact Information
Email
d****@pharmenabletx.com
Unlock
Company Information
Professional Summary
David Vidal serves as Chief Technology Officer at PharmEnable. PharmEnable operates in the research sector with approximately 21.0 employees. The company is headquartered in Barcelona, Catalonia. To date, PharmEnable has raised 9729668.0 in total funding, with the most recent round being Other.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
1,458 executive contacts are available in Catalonia.
-
•
Our database includes 201,468 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Google Font API
Nginx
Mobile Friendly
Google Tag Manager
WordPress.org
reCAPTCHA
Keywords
biotechnology research
drug discovery
small molecules
ai drug discovery
medicinal chemistry
cancer therapeutics
neurodegenerative diseases
gpcr targets
molecular modeling
chemical diversity
inaccessible targets
therapeutic innovation
protein structure design
oral small molecules
novel drug candidates
synthetic feasibility
small molecule design
collaborative drug discovery
multi-dimensional chemical space
bioavailability
lead optimization
clinical development
structurally diverse molecules
pharmaceutical research
targeted therapy
biologic specificity
preclinical pipeline
machine learning
computational chemistry
advanced drug design
scientific expertise
collaboration
novel chemical space
strategic partnerships
biotech innovation
clinical candidate selection
drug design methodologies
medicinal chemistry expertise
technology collaboration
therapeutic development
drug repurposing
diversity-oriented synthesis
multidisciplinary approach
chemical research
custom drug design
high-quality leads
pharmaceutical collaborations
clinical trials
artificial intelligence
information technology & services
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like David Vidal in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at PharmEnable.
David Vidal's Position in the MessageCEO Database
- •David Vidal is 1 of 1 verified executive contact we track at PharmEnable.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •1,430 verified executive contacts in Catalonia are in the database.
- •37 verified contacts work at research companies in the 21.0 employee range (same size as PharmEnable).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach David Vidal directly?
David Vidal's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at PharmEnable. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does David Vidal work for?
David Vidal is Chief Technology Officer at PharmEnable, a company in the research sector with 21.0 employees. The company is based in Barcelona, Catalonia.
Can I pitch or sell to David Vidal?
As Chief Technology Officer at PharmEnable, David Vidal is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Vidal directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is David Vidal in?
David Vidal works in the research industry as Chief Technology Officer at PharmEnable. MessageCEO provides verified contact information for executives across all major industries.
Is David Vidal's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Vidal's profile is kept up-to-date with the latest available information.
Last updated: July 25, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans